Niepubliczny Zakład Opieki Zdrowotnej Vivamed Jadwiga Miecz
- Address
- lock Available on a paid plan
Niepubliczny Zakład Opieki Zdrowotnej Vivamed Jadwiga Miecz - Inflammatory Bowel Disease Research Center
NZOZ Vivamed Jadwiga Miecz is a specialized clinical research facility with expertise in inflammatory bowel disease (IBD) investigations. The center focuses on evaluating novel therapeutic approaches for patients with chronic gastrointestinal inflammatory conditions, with particular emphasis on comparative effectiveness studies and long-term safety assessments of emerging biologics and oral formulations.
- Ulcerative colitis remission induction therapies and mesalazine formulations
- Advanced biologic treatments including tulisokibart for IBD management
- Long-term safety and tolerability studies in Crohn's disease and ulcerative colitis
The research center conducts comprehensive phase III non-inferiority trials and multi-center studies that incorporate rigorous clinical and endoscopic assessment methodologies. Their research portfolio demonstrates a commitment to advancing treatment options for patients with active mild to moderate ulcerative colitis and complex Crohn's disease, utilizing both established oral therapies and innovative immunomodulatory agents to improve patient outcomes and quality of life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1Merck Sharp & Dohme LLC2active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Merck Sharp & Dohme LLC4trials
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Niepubliczny Zakład Opieki Zdrowotnej Vivamed Jadwiga Miecz
lock Showing 1 of 23 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study in Healthy Participants Followed by a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study in Participants with Moderate-to-Severe Active Ulcerative Colitis. | Xencor Inc. | Phase II | Recruiting | Jan 2026 | — |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tulisokibart | 4 | Unknown | 2024-08-20 | 2025-09-29 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.